Question

Is stem cell therapy for Knee Osteoarthritis FDA-approved?

The FDA consumer alert states that the promoted stem-cell and exosome products it addresses are not approved for knee pain or osteoarthritis. Verify any exact authorised product and indication; a same-day autologous procedure is not automatically exempt or approved.

Medical review statusPending clinical sign-offLast evidence update: 2026-08-05Methodology and editorial standards

Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.

How stem cells are studied for Knee Osteoarthritis

Knee osteoarthritis is a whole-joint disorder involving cartilage, bone, synovium, muscle and mechanics. Autologous marrow or adipose preparations, culture-expanded MSCs, stromal vascular fraction and exosomes are distinct products. An anti-inflammatory signal or injection into the joint does not establish cartilage regrowth or prevention of joint replacement.

Am I a candidate? → · Knee Osteoarthritis: full overview → · Knee Osteoarthritis cost → · Cost →

Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.

Sources & further reading

More on this condition

Explore all sections · Data & downloads

Is stem cell therapy for Knee Osteoarthritis FDA-approved?

How stem cells are studied for Knee Osteoarthritis

Sources & further reading

More questions about Knee Osteoarthritis

More on this condition

Compare cell-therapy evidence, registered studies and published price observations.